Inventiva S.A. Made Headway
Mon, Oct 14, 2024 at 07:09 PM
Inventiva S.A. (IVA:NASDAQ) shot up at $2.67, representing a gain of 41.3%. On Mon, Oct 14, 2024, IVA:NASDAQ hit a New 2-Week High of $2.67. The stock got featured on our News Catalysts scanner on Mon, Oct 14, 2024 at 01:27 PM in the 'AGREEMENT' category. From Mon, Sep 30, 2024, the stock recorded 50.00% Up Days and 45.45% Green Days
About Inventiva S.A. (IVA:NASDAQ)
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation.
Top 10 Gainers:
- Reneo Pharmaceuticals Inc. (RPHM:NASDAQ), 952.02%
- Tevogen Bio Holdings Inc Com (TVGN:NASDAQ), 187.14%
- Bright Minds Biosciences Inc. (DRUG:NASDAQ), 132.71%
- Verb Technology Company, Inc. (VERB:NASDAQ), 58.41%
- Rani Therapeutics Holdings Inc. (RANI:NASDAQ), 57.43%
- Longboard Pharmaceuticals Inc. (LBPH:NASDAQ), 51.65%
- Expion360 Inc. (XPON:NASDAQ), 47.28%
- Vision Marine Technologies Inc. (VMAR:NASDAQ), 44.1%
- Inventiva S.A. (IVA:NASDAQ), 41.27%
- Big Tree Cloud Holdings Limited (DSY:NASDAQ), 38.9%